GHRH and lipodystrophy: Tesamorelin (Egrifta) is a human growth hormone-releasing factor (GRF) analog for lipodystrophy induced by antiviral therapy in AIDS patients (Lake et al., 2021) and has the primary structure Hexenoil-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2.